Sutro Biopharma Inc (STRO)
2.51
-0.02
(-0.79%)
USD |
NASDAQ |
Nov 22, 16:00
2.52
+0.01
(+0.40%)
After-Hours: 20:00
Sutro Biopharma Price: 2.51 for Nov. 22, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 22, 2024 | 2.52 | 2.60 | 2.45 | 2.51 | 840260.0 |
| Nov 21, 2024 | 2.66 | 2.768 | 2.52 | 2.53 | 925336.0 |
| Nov 20, 2024 | 2.70 | 2.81 | 2.55 | 2.67 | 884928.0 |
| Nov 19, 2024 | 2.73 | 2.87 | 2.65 | 2.70 | 2.925M |
| Nov 18, 2024 | 2.91 | 2.95 | 2.600 | 2.75 | 1.170M |
| Nov 15, 2024 | 3.46 | 3.46 | 2.82 | 2.89 | 1.547M |
| Nov 14, 2024 | 3.89 | 4.06 | 3.42 | 3.45 | 702562.0 |
| Nov 13, 2024 | 4.16 | 4.25 | 3.96 | 3.96 | 245288.0 |
| Nov 12, 2024 | 4.34 | 4.34 | 4.08 | 4.08 | 397189.0 |
| Nov 11, 2024 | 4.47 | 4.60 | 4.25 | 4.40 | 777717.0 |
| Nov 08, 2024 | 4.12 | 4.46 | 4.01 | 4.38 | 518752.0 |
| Nov 07, 2024 | 4.14 | 4.41 | 4.11 | 4.16 | 577825.0 |
| Nov 06, 2024 | 3.87 | 4.235 | 3.86 | 4.14 | 829082.0 |
| Nov 05, 2024 | 3.71 | 3.86 | 3.595 | 3.84 | 519412.0 |
| Nov 04, 2024 | 3.49 | 3.72 | 3.355 | 3.69 | 801574.0 |
| Nov 01, 2024 | 3.35 | 3.74 | 3.33 | 3.55 | 1.243M |
| Oct 31, 2024 | 3.53 | 3.54 | 3.22 | 3.25 | 448797.0 |
| Oct 30, 2024 | 3.55 | 3.70 | 3.54 | 3.56 | 358665.0 |
| Oct 29, 2024 | 3.65 | 3.70 | 3.485 | 3.55 | 591601.0 |
| Oct 28, 2024 | 3.49 | 3.69 | 3.49 | 3.58 | 940862.0 |
| Oct 25, 2024 | 3.46 | 3.545 | 3.40 | 3.45 | 294283.0 |
| Oct 24, 2024 | 3.52 | 3.57 | 3.435 | 3.46 | 217740.0 |
| Oct 23, 2024 | 3.50 | 3.545 | 3.38 | 3.50 | 258540.0 |
| Oct 22, 2024 | 3.62 | 3.67 | 3.50 | 3.53 | 404667.0 |
| Oct 21, 2024 | 3.68 | 3.68 | 3.48 | 3.64 | 263305.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
2.07
Minimum
Nov 13 2023
27.54
Maximum
Jan 22 2021
9.595
Average
7.42
Median
Nov 25 2022
Price Benchmarks
| Fulcrum Therapeutics Inc | 3.25 |
| NovaBay Pharmaceuticals Inc | 0.681 |
| Palatin Technologies Inc | 0.96 |
| iBio Inc | 2.64 |
| Theriva Biologics Inc | 1.28 |
Price Related Metrics
| PS Ratio | 1.114 |
| Price to Book Value | 1.861 |
| Earnings Yield | -64.14% |
| Market Cap | 206.97M |